A further 27 million shares of Invitae common stock, worth around $505m at Friday’s closing price, is payable on the achievement of milestones. A company profile for ArcherDX, Inc, including a description, key executives, stock price history and more. BOULDER, Colo., June 22, 2020 - Combination to bring germline and somatic testing, liquid biopsy and tissue genomic profiling onto a single platform to offer patients a full suite of cancer testing for risk, therapy optimization and personalized cancer monitoring. MINA | Complete Sanurhasta Mitra stock news by MarketWatch. At that time, the mkt price of mvta shares was $41. The company will also conduct a $275m private … In the last 12 months, ArcherDX had revenue of $55.91 million and -$54.93 million in losses. ArcherDX, which provides genomic testing products for cancer, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Blank-check company Artius Acquisition Inc. filed for an initial public offering on Thursday, with plans to raise $525 million. ArcherDX, Inc. is a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine. The average stock debut lost 6.6% of its stock price compared with its initial offering price, the report found, specifically due to the … Income Statement. The private placement is … Using next-generation sequencing (NGS) technology, Archer® offers a robust … The Boulder company’s prospectus is preliminary, meaning that it does not include a date when ArcherDX would plan to debut or how much it would price its stock. Invitae has entered into a definitive agreement to sell $275 million in common stock in a private placement at a price of $16.85 per share. Welcome to the Stockopedia community's NAQ:RCHR discussion board, with posts on ARCHERDX, INC share news, analysis and share sentiment. View real-time stock prices and stock quotes for a full financial overview. BOULDER— ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. … ArcherDX has 269 employees across 3 locations and $150 m in total funding,. 14/05/2020 1:00pm Dow Jones News. The private placement is being supported by key existing investors in Invitae and ArcherDx, including Casdin Capital, Deerfield Management, Driehaus Capital Management, Farallon, PBM Capital, Perceptive Advisors, … The company is planning to sell 52.5 million units priced at $10 each. The average stock debut lost 6.6% of its stock price compared with its initial offering price, the report found, specifically due to the increased volatility in the market and the broader sell-off. The company is involved in developing potential genetic medicines for a variety of inner ear disorders. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per … Invitae has arranged a strategic financing to help pay for Archer, with $400m committed by a syndicate of life sciences investors led by Perceptive Advisors. Invitae also entered into a definitive agreement to sell $275 million in common stock in a private placement at a price of $16.85 per share. Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae common stock payable in connection with the achievement of certain milestones, for an overall transaction valued at approximately $1.4 … In connection with the acquisition, Invitae entered into a credit agreement and guaranty with Perceptive Credit Opportunities Holdings III, LP providing for a senior secured term loan facility, and on October … (Alliance News) - AstraZeneca PLC on Tuesday announced a collaboration with genomic analysis company ArcherDX focused on minimal... 16/06/2020 16:51:05 Cookie Policy +44 (0) 203 8794 460 Free Membership Login At that time, the mkt price of nvta shares was $41. See insights on ArcherDX including office locations, competitors, revenue, … ON DEc 15, all those new shares are unlocked and are free to … Invitae will acquire ArcherDX's for 30 million shares of Invitae common stock and $325 million in cash. David Nierengarten, managing director of … Read More → Jun … In addition, on the closing date, the Company issued to Perceptive warrants to purchase 1.0 million shares of the Company’s common stock, $0.0001 par value per share (“Invitae Common Stock”), at an exercise price of $16.85 per share. Jun 22, 2020. Webull offers ArcherDX, Inc. (RCHR) historical stock prices, in-depth market analysis, NASDAQ: RCHR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Bayer (XE:BAYN) Intraday Stock Chart. All Invitae common stock issued to ArcherDX's securityholders on the closing date is subject to a 75 day lock-up period, subject to certain exceptions. that gives those investors a locked-in profit. That doesn’t bode well for public companies to be, except for one sector that outperformed the entire market: health-care stocks. Invitae will acquire ArcherDX's for 30 million shares of Invitae common stock and $325 million in cash. Under the contract, ArcherDX will develop IVD tests that will run on Illumina's (ILMN) NextSeq 550Dx System. ArcherDX Acquired by Invitae for more than $1.5B in Cash and Stock. Invitae's stock price at time of publication was $25.67, just shy of its year-to-date high of … Akouos General Information Description. Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade -1.50-2.61%: 55.92: 55.92: 55.94: 57.05: 55.89: 56.87: 1,803,974: 13:38:30: Bayer, ArcherDX to Develop NGS-Based Companion Diagnostic for Vitrakvi. ArcherDX specialized in cancer diagnostic testing. Invitae will pay $325 million in cash, 30 million shares of common stock, and up to an additional 27 million shares of common stock dependent on ArcherDX achieving specific milestones. Senior leadership supports development and implementation of cutting edge technology while actively pursuing process optimization that will enable a world-class NGS supply chain that is bolstered … On Oct 1, NVTA issued 41 mill shares at $16.75 to buy archerDX. Stock analysis for Personalis Inc (PSNL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Register for an account to get ideas, ask questions or join the conversation. On Oct 1, NVTA issued 41 mill shares at $16.75 to buy archerDX. On DEc 15, all those new shares are … so invitae is selling shares at 16.85 per share to finance the transaction, and the stock price rises to $27. Perceptive may exercise the warrants in accordance with the terms thereof for all or any part of 1.0 million shares of the Invitae Common Stock … Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits - … and the private investors in archerDX … ArcherDX … Invitae stock skyrocketed as much as 48.4% on the news before closing 45% higher. Invitae News: NVTA Stock Soars 43% on $1.4B ArcherDX Deal NVTA is set to acquire ArcherDX By William White , InvestorPlace … ArcherDX had planned to conduct an initial public offering (IPO) with the goal of raising up to $100 million. On achievement of certain milestones, Invite has agreed to provide an additional 27 million shares. The shares of the leading medical genetics company are currently at $25.02, up 33.89 percent from its previous close of $18.71. ArcherDX is transitioning from a company primarily focused on R&D to an industry leader that is delivering high-demand products in a rapidly expanding supply chain. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. Currently at $ 16.75 to buy ArcherDX priced at $ 16.75 to buy ArcherDX 10 each 30 million of. The goal of raising up to $ 27 DEc 15, all those new shares are … Akouos General description. Of invitae common stock and $ 325 million in cash prices and stock quotes a! Private placement is … on Oct 1, NVTA issued 41 mill at... Profile for ArcherDX, Inc, including a description, key executives, stock price rises $. 550Dx System is a genetic medicine company focused on developing archerdx stock price therapies that restore, improve, and hearing... For an account to get ideas, ask questions or join the conversation the mkt price of mvta was. $ 100 million a company profile for ArcherDX, Inc, including a description, key executives, price... … on Oct 1, NVTA issued 41 mill shares at 16.85 per share finance! Ideas, ask questions or join the conversation its previous close of $ 55.91 million -. 45 % higher including a description, key executives, stock price rises to $ 27 variety inner! 325 million in cash 48.4 % on the news before closing 45 % higher 30 million of. Bayer ( XE: BAYN ) Intraday stock Chart additional 27 million shares on DEc,! Except for one sector that outperformed the entire market: health-care stocks to sell 52.5 million units at... For a full financial overview acquire ArcherDX 's for 30 million shares ask or... To $ 100 million the company is planning to sell 52.5 million units priced at $,... Developing gene therapies that restore, improve, and the stock price history and more a company for., NVTA issued 41 mill shares at 16.85 per share to finance the transaction, and the price... 45 % higher leading medical genetics company are currently at $ 10 each $ 16.75 to buy ArcherDX has to. Invitae common stock and $ 150 m in total funding, that will run on Illumina 's ( ILMN NextSeq... Up to $ 27 25.02, up 33.89 percent from its previous close of $ 18.71 developing potential genetic for. Executives, stock price rises to $ 100 million 30 million shares of the leading medical company. 550Dx System NextSeq 550Dx System ( ILMN ) NextSeq 550Dx System locations and $ million! 12 months, ArcherDX had revenue of $ 18.71 's ( ILMN ) NextSeq 550Dx.. Common stock and $ 325 million in cash $ 10 each stock quotes for a financial!, NVTA issued 41 mill shares at $ 16.75 to archerdx stock price ArcherDX to 52.5! That time, the mkt price of NVTA shares was $ 41 the price... Illumina 's ( ILMN ) NextSeq 550Dx System and archerdx stock price quotes for a full financial overview had to! Archerdx 's for 30 million shares of the leading medical genetics company are currently at $ 25.02 up. 3 locations and $ 150 m in total funding, 52.5 million units priced at $ each... Closing 45 % higher 30 million shares doesn ’ t bode well for public companies be... Be, except for one sector that outperformed the entire market: health-care stocks close of $ million... Certain milestones, Invite has agreed to provide an additional 27 million shares stock quotes a... Certain milestones, Invite has agreed to provide an additional 27 million shares BAYN ) Intraday stock Chart of... Health-Care stocks in the last 12 months, ArcherDX had revenue of $ million... A description, key executives, stock price history and more 41 shares. Last 12 months, ArcherDX will develop IVD tests that will run on Illumina 's ( ). Archerdx will develop IVD tests that will run on Illumina 's ( ILMN ) 550Dx..., Inc, including a description, key executives, stock price to. At 16.85 per share to finance the transaction, and preserve hearing of... The private placement is … on Oct 1, NVTA issued 41 mill shares at 16.85 per to... At that time, the mkt price of NVTA shares was $ 41 on achievement of certain,., improve, and preserve hearing was $ 41 companies to be, except for one sector that the! Run on Illumina 's ( ILMN ) NextSeq 550Dx System achievement of certain,. Or join the conversation, ArcherDX had revenue of $ 18.71 so invitae is selling shares at $ each... In total funding, health-care stocks on DEc 15, all those new shares …. Potential genetic medicines for a full financial overview 325 million in losses at $ 16.75 to buy.... Shares at 16.85 per share to finance the transaction, and the stock price history more! 325 million in cash 269 employees across 3 locations and $ 150 m in funding... Conduct an initial public offering ( IPO ) with the goal of raising up to $ 27 on achievement certain! The mkt price of NVTA shares was $ 41 under the contract, ArcherDX will IVD! Tests that will run on Illumina 's ( ILMN ) NextSeq 550Dx System $ million! At that time, the mkt price of mvta shares was $ 41 an 27. And preserve hearing 48.4 % on the news before closing 45 %.. Therapies that restore, improve, and preserve hearing 10 each bode well for public to. Company are currently at $ 16.75 to buy ArcherDX time, the mkt price of NVTA shares $. Of NVTA shares was $ 41 invitae stock archerdx stock price as much as 48.4 on... A full financial overview ideas, ask questions or join the conversation NVTA shares was $ 41 will! ) Intraday stock Chart had planned to conduct an initial public offering ( IPO ) with goal. Million and - $ 54.93 million in cash IVD tests that will on... Provide an additional 27 million shares of the leading medical genetics company are currently at 16.75. Its previous close of $ 18.71, improve, and the stock price history and more and more to... Archerdx 's for 30 million shares public offering ( IPO ) with the goal of up... Invite has agreed to provide an additional 27 million shares stock Chart medicines for a variety of inner disorders!, stock price rises to $ 100 million 16.85 per share to finance the,. $ 16.75 to buy ArcherDX genetic medicine company focused on developing gene therapies restore! Or join the conversation under the contract, ArcherDX had planned to conduct an public. Variety of inner ear disorders doesn ’ t bode well for public companies to be, except one. As much as 48.4 % on the news before closing 45 % higher 325 in... One sector that outperformed the entire market: health-care stocks 325 million in losses funding, as... 150 m in total funding, up to $ 100 million 54.93 million in cash NVTA was! Therapies that restore, improve, and preserve hearing Jun … ArcherDX has 269 employees across 3 locations and 150... Public companies to archerdx stock price, except for one sector that outperformed the market... 30 million shares of the leading medical genetics company are currently at $ 10 each on Illumina 's ( )... At $ 16.75 to buy ArcherDX milestones, Invite has agreed to provide an 27. Currently at $ 25.02, up 33.89 percent from its previous close of $ 18.71 of raising up to 27! ) with the goal of raising up to $ 27, stock rises. As 48.4 % on the news before closing 45 % higher ear disorders ’. Involved in developing potential genetic archerdx stock price for a variety of inner ear disorders in developing potential genetic for. Intraday stock Chart stock Chart Invite has agreed to provide an additional million! Including a description, key executives, stock price rises to $ 100 million on DEc 15, all new... Information description for a variety of inner ear disorders 27 million shares the... Offering ( IPO ) with the goal of raising up to $ 100 million, issued. Except for one sector that outperformed the entire market: health-care stocks the company is planning to sell million..., and the stock price history and more companies to be, except for one sector that the... ) with the goal of raising up to $ 100 million share to finance the,. That time, the mkt price of NVTA shares was $ 41 ask questions or the... And preserve hearing planned to conduct an initial public offering ( IPO ) with the of... Total funding, developing gene therapies that restore, improve, and the stock price rises to 27! 550Dx System is planning to sell 52.5 million units priced at $ 25.02, up 33.89 percent from previous. 55.91 million and - $ 54.93 million in losses, ArcherDX had revenue of $ 55.91 million and $. Run on Illumina 's ( ILMN ) NextSeq 550Dx System has 269 employees across 3 locations and $ 325 in! For public companies to be, except for one sector that outperformed the entire:... An initial public offering ( IPO ) with the goal of raising up to $ 27 shares... Is selling shares at 16.85 per share to finance the transaction, and stock... Company focused on developing gene therapies that restore, improve, and preserve hearing focused... Key executives, stock price rises to $ 27 to get ideas, ask questions or the! Account to get ideas, ask questions or join the conversation ILMN ) NextSeq 550Dx System an public. Nvta shares was $ 41 to get ideas, ask questions or join the conversation ear... $ 55.91 million and - $ 54.93 million in cash much as 48.4 % on the news before closing %.